Literature DB >> 9821162

Decreases in plasma A beta 1-40 levels with aging in non-demented elderly with ApoE-epsilon 4 allele.

N Pomara1, B Shao, T Wisniewski, P D Mehta.   

Abstract

This report examines plasma amyloid beta proteins A beta 40 and A beta 42 and apolipoprotein E (apoE) levels and their relationships with age in non-demented older adults with (N = 32) or without the apoE-epsilon 4 allele (N = 94). A beta levels did not differ between the groups whereas the epsilon 4 allele was associated with a significant reduction in plasma apoE. In subjects with the epsilon 4 allele, increasing age was associated with significant reduction in plasma A beta 40. Subjects without the epsilon 4 allele showed a significant positive correlation between A beta 40 and A beta 42 levels. There was also a significant correlation between plasma A beta 40 and apoE levels in all subjects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821162     DOI: 10.1023/a:1020936222286

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  22 in total

1.  Increased plasma amyloid beta protein 1-42 levels in Down syndrome.

Authors:  P D Mehta; A J Dalton; S P Mehta; K S Kim; E A Sersen; H M Wisniewski
Journal:  Neurosci Lett       Date:  1998-01-23       Impact factor: 3.046

2.  Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.

Authors:  E Boerwinkle; G Utermann
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

3.  Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.

Authors:  P Bertrand; J Poirier; T Oda; C E Finch; G M Pasinetti
Journal:  Brain Res Mol Brain Res       Date:  1995-10

4.  Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype.

Authors:  S Kataoka; M Paidi; B V Howard
Journal:  Clin Chem       Date:  1994-01       Impact factor: 8.327

5.  Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease.

Authors:  R Benjamin; A Leake; P G Ince; R H Perry; I G McKeith; J A Edwardson; C M Morris
Journal:  Neurodegeneration       Date:  1995-12

6.  Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

Authors:  T Wisniewski; E M Castaño; A Golabek; T Vogel; B Frangione
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

7.  Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; M Goedert; K H Weisgraber; L M Dong; R Jakes; D Y Huang; M Pericak-Vance; D Schmechel; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

Review 8.  Apolipoprotein E and Alzheimer disease.

Authors:  W J Strittmatter; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.

Authors:  T Lehtimäki; T Pirttilä; P D Mehta; H M Wisniewski; H Frey; T Nikkari
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

10.  Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.

Authors:  T Polvikoski; R Sulkava; M Haltia; K Kainulainen; A Vuorio; A Verkkoniemi; L Niinistö; P Halonen; K Kontula
Journal:  N Engl J Med       Date:  1995-11-09       Impact factor: 91.245

View more
  2 in total

1.  A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals.

Authors:  Davide Bruno; Michel J Grothe; Jay Nierenberg; Henrik Zetterberg; Kaj Blennow; Stefan J Teipel; Nunzio Pomara
Journal:  Neuropsychologia       Date:  2015-01-19       Impact factor: 3.139

2.  Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients.

Authors:  Mark van den Boogaard; Matthijs Kox; Kieran L Quinn; Theo van Achterberg; Johannes G van der Hoeven; Lisette Schoonhoven; Peter Pickkers
Journal:  Crit Care       Date:  2011-12-29       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.